Correlation Engine 2.0
Clear Search sequence regions

  • chronic disease (1)
  • FKRP (1)
  • fkrp protein, human (1)
  • food (1)
  • gene therapies (1)
  • help (1)
  • humans (1)
  • limb (11)
  • protein human (1)
  • rna (1)
  • sarcoglycan (1)
  • therapies (1)
  • Sizes of these terms reflect their relevance to your search.

    The limb-girdle muscular dystrophies (LGMDs) are a group of inherited muscle disorders with a common feature of limb-girdle pattern of weakness, caused by over 29 individual genes. This article describes the classification scheme, common subtypes, and the management of individuals with LGMD. Advances in genetic testing and next-generation sequencing panels containing all of the LGMD genes have led to earlier genetic confirmation, but also to more individuals with variants of uncertain significance. The LGMDs include disorders with autosomal recessive inheritance, which are often due to loss-of-function mutations in muscle structural or repair proteins and typically have younger ages of onset and more rapidly progressive presentations, and those with autosomal dominant inheritance, which can have older ages of presentation and chronic progressive disease courses. All cause progressive disability and potential loss of ability to walk or maintain a job due to progressive muscle wasting. Certain mutations are associated with cardiac or respiratory involvement. No disease-altering therapies have been approved by the US Food and Drug Administration (FDA) for LGMDs and standard treatment uses a multidisciplinary clinic model, but recessive LGMDs are potentially amenable to systemic gene replacement therapies, which are already being tested in clinical trials for sarcoglycan and FKRP mutations. The dominant LGMDs may be amenable to RNA-based therapeutic approaches. International efforts are underway to better characterize LGMDs, help resolve variants of uncertain significance, provide consistent and improved standards of care, and prepare for future clinical trials. Copyright © 2022 American Academy of Neurology.


    Nicholas E Johnson, Jeffrey M Statland. The Limb-Girdle Muscular Dystrophies. Continuum (Minneapolis, Minn.). 2022 Dec 01;28(6):1698-1714

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 36537976

    View Full Text